Game ReleaseApril 24 2012
SHARK DASH CLIMBS TO THE TOP OF THE APP STORE AND GOOGLE PLAY
Shark Dash, a new hit franchise from Gameloft, has climbed into the Top 5 paying games on the App Store since its release on April 19, 2012, receiving exceptional consumer ratings in the United States (4.5/5), France (4.5/5), the United Kingdom (4.5/5), Germany (4.5/5), Mexico (4.5/5) and Canada (4.5/5).
Shark Dash is a highly addictive game that takes physics puzzle games to new heights with a fun and unique cartoon style design starring lovable little bath toys!
“We are very proud to offer such a novel gaming experience for our fans to enjoy,” states Julien Fournials, Gameloft Senior Vice President of Production.The extremely accessible gameplay, the never-seen use of water at the heart of the game system, and the quality of its graphics make Shark Dash one of the most polished arcade games on the App Store right now. We invested a lot of resources in the creation of a unique world and an original storyline starring irresistible characters”
Shark Dash has been available since April 19, 2012, for $0.99 on the App Store and Google Play.
A leading global publisher of digital and social games, Gameloft® has established itself as one of the top innovators in its field since 2000. Gameloft creates games for all digital platforms, including mobile phones, smartphones and tablets (including Apple® iOS and Android® devices), set-top boxes, connected TVs and consoles. Gameloft partners with leading international brands such as UNO®, Spider-Man®, James Cameron’s Avatar™, Ferrari® and Sonic Unleashed®. Gameloft also operates its own established franchises, such as Real Football, Asphalt™, Modern Combat 3: Fallen Nation and N.O.V.A. 2: Near Orbit Vanguard Alliance®. Gameloft is present on all continents, distributes its games in 100 countries and employs over 4,500 developers.
Gameloft is listed on the Paris Stock Exchange (ISIN: FR0000079600, Bloomberg: GFT FP, Reuters: GLFT.PA).
Gameloft’s sponsored Level 1 ADR (ticker: GLOFY) is traded OTC in the US.